Table 1.
Model | Parameters | Estimate | SE, covariance step | RSE (%), covariance step | SE, bootstrapping | RSE (%), bootstrapping | Median (95% CI), bootstrapping | |
---|---|---|---|---|---|---|---|---|
POa | k eo | 0.034 | 4.9 | 13.8 | 0.034 (0.026, 0.046) | |||
B 1 | −4.03 | 0.20 | 0.36 | −4.09 (−4.90, −3.49) | ||||
B 2–B 1 | −4.33 | 4.9 | 13.8 | −4.37 (−5.72, −3.39) | ||||
Slope | 20.0 | 12.1 | 14.3 | 20.4 (15.4, 26.5) | ||||
CV% (slope) | 78.9 | 12.4 | 15.0 | 78.0 (57.8, 101.3) | ||||
DTMMb | B 1,0 | −5.48 | 0.40 | 0.43 | −5.54 (−6.53, −4.83) | |||
B 2,0–B 1,0 | −1.58 | 15.5 | 15.8 | −1.60 (−2.17, −1.19) | ||||
B 1,1 | 1.35 | 0.22 | 0.19 | 1.33 (0.97,1.71) | ||||
B 2,1–B 1,1 | −9.86 | 7.7 | 18.5 | −9.88 (−19.90, −8.53) | ||||
B 1,2 | 0.394 | 0.33 | 0.38 | 0.352 (−0.454, 1.083) | ||||
B 2,2–B 1,2 | −0.0966 (fix) | NA | NA | NA | ||||
Slope | 18.8 | 12.4 | 13.2 | 19.1 (14.8, 24.9) | ||||
CV% (slope) | 21.1 | 28.7 | 23.7 | 20.4 (9.63, 29.95) | ||||
CTMMc | Slope01 | 0.053 | 21.6 | 23.4 | 0.053 (0.031, 0.077) | |||
Slope10 | 32.14 | 50.1 | 40.8 | 36.60 (14.30, 75.19) | ||||
Slope02 | 0.014 | 39.3 | 35.6 | 0.013 (0.006, 0.024) | ||||
Slope20 | 8.94 | 41.3 | 23.0 | 9.87 (5.99, 14.88) | ||||
Slope12 | 0.1 × Slope01 | NA | NA | NA | ||||
K 10 | 0.115 | 44.6 | 45.5 | 0.141 (0.068, 0.368) | ||||
K 20 | K10 | NA | NA | NA | ||||
K 21 | 0.01 × K10 | NA | NA | NA | ||||
CV% (slope01) | 86.0 | 35.9 | 68.3 | 87.8 (41.6, 199.8) | ||||
CV% (slope10) | 97.5 | 39.2 | 39.1 | 100.5 (71.7, 183.4) | ||||
CV% (slope02) | 146.3 | 17.6 | 18.4 | 139.3 (89.3, 189.8) | ||||
CV% (slope20) | 80.4 | 33.4 | 39.5 | 79.7 (19.2, 139.8) |
Only the parameter estimates related to the adverse event analysis were included in the table. The parameter estimates related to the pharmacokinetics of vismodegib was included in Model S1 .
CI, confidence interval; Median (95% CI) bootstrapping, median and 95% CI from “percentile confidence intervals” (bootstrap_results.csv); NA, not applicable; RSE, relative standard error; SE, standard error.
a K eo is shown on a normal scale but was estimated in the log domain. The RSE% presented in “RSE (%) covariance step” or “RSE% bootstrapping” is the SE of the logged parameter *100 that is approximately equal to the RSE% of the parameter on the normal domain. , baseline of logit probability for AE ≥ m (m = 1, 2/3); coefficient of variation (CV%) (parameter), standard deviation of the interindividual variability for certain parameter that derived by “sqrt(omega)*100”; PO, proportional odds model; RSE% bootstrapping, relative standard error from bootstrapping that was derived by “(bootstrap SD/median)*100”, bootstrap SD is the standard deviation of parameter estimates that is “standard.errors”; RSE% for CV% are derived by RSE% for omega/2 for the RSE% from covariance step and bootstrapping; RSE (%) covariance step, relative standard error from nonlinear mixed‐effect modeling (NONMEM) covariance step; SE bootstrapping, “standard.errors” from bootstrapping results (bootstrap_results.csv) (same as SE covariance step, only apply to B1); SE covariance step, standard error from NONMEM covariance step (only apply to B1 as it can take either positive or negative value; RSE by SE/THETA is not a proper measure of uncertainty in this case); Slope, population mean increase in per unit increase in exposure. bSE covariance step and SE bootstrapping were only applied to B 1,0, B 1,1, B 1,2, as they can take either positive or negative value (same as B1 for the PO model). , baseline of , given the preceding grade ; B 2,2–B 1,2, the transition probability in logit scale from grade 2/3 to 1, which was fixed to the estimated value (−0.0966) with no change in the objective function values; DTMM, discrete‐time Markov model. cAll of the slope parameters and K 10 are shown on normal scale but were estimated in the log domain. The RSE% presented in “RSE (%) covariance step” or “RSE% bootstrapping” are the SE of the logged parameter *100 that is approximately equal to the RSE% of the parameter on the normal domain. CTMM, continuous‐time Markov model; , slope for transition , with as the preceding grade and as the current grade; K g1g2, baseline of without treatment (, first‐order transfer rate constant from high to low grade ()).